Short Interest in Corindus Vascular Robotics Inc (CVRS) Rises By 6.4%

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 14,433,050 shares, a growth of 6.4% from the March 29th total of 13,569,380 shares. Currently, 12.2% of the shares of the stock are short sold. Based on an average trading volume of 1,229,430 shares, the days-to-cover ratio is presently 11.7 days.

Shares of NYSEAMERICAN CVRS opened at $2.00 on Friday. Corindus Vascular Robotics has a 52 week low of $0.70 and a 52 week high of $2.54.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last issued its earnings results on Tuesday, March 12th. The medical equipment provider reported ($0.04) EPS for the quarter, hitting the consensus estimate of ($0.04). The firm had revenue of $4.67 million during the quarter, compared to analysts’ expectations of $5.60 million.

In other Corindus Vascular Robotics news, major shareholder Hudson Executive Capital Lp purchased 2,899,391 shares of the firm’s stock in a transaction on Tuesday, March 12th. The shares were purchased at an average cost of $1.38 per share, with a total value of $4,001,159.58. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Louis A. Cannon purchased 573,798 shares of the firm’s stock in a transaction on Tuesday, March 12th. The shares were acquired at an average cost of $1.38 per share, for a total transaction of $791,841.24. The disclosure for this purchase can be found here. Insiders have acquired 3,483,189 shares of company stock worth $4,811,001 over the last three months.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Canton Hathaway LLC purchased a new position in shares of Corindus Vascular Robotics in the first quarter worth $63,000. Jane Street Group LLC purchased a new position in Corindus Vascular Robotics during the 4th quarter valued at $36,000. HRT Financial LLC purchased a new position in Corindus Vascular Robotics during the 4th quarter valued at $44,000. Virtu Financial LLC purchased a new position in Corindus Vascular Robotics during the 4th quarter valued at $64,000. Finally, Citadel Advisors LLC increased its position in Corindus Vascular Robotics by 205.4% during the 3rd quarter. Citadel Advisors LLC now owns 115,728 shares of the medical equipment provider’s stock valued at $164,000 after purchasing an additional 77,829 shares during the period.

COPYRIGHT VIOLATION NOTICE: “Short Interest in Corindus Vascular Robotics Inc (CVRS) Rises By 6.4%” was published by Mayfield Recorder and is owned by of Mayfield Recorder. If you are viewing this piece on another publication, it was illegally copied and republished in violation of U.S. and international copyright laws. The original version of this piece can be viewed at https://mayfieldrecorder.com/2019/04/27/short-interest-in-corindus-vascular-robotics-inc-cvrs-rises-by-6-4.html.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures.

Read More: What is a Leveraged Buyout (LBO)?

Receive News & Ratings for Corindus Vascular Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Corindus Vascular Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.